Drug Injuries

Amiodarone Lawsuit

The side effects of Amiodarone can actually worsen an arrhythmia. Drug companies have marketed it as a first-line medication, contrary to what the FDA approved it for.

Uloric Lawsuit

Uloric lawsuits are being filed for heart attack and stroke complications. The popular gout medication recently received a boxed warning from the U.S. Food & Drug Administration (FDA) due to an increased risk of heart-related death. Learn more from Johnson // Becker and contact us to see if you qualify to file a Uloric lawsuit.

Xeljanz Lawsuit

Xeljanz (tofacitinib) was found to increase a risk of blood clots in the lungs or death during a postmarketing study of the medication.

Viberzi Lawsui

Patients taking Viberzi to treat irritable bowel syndrome may be at risk of suffering from pancreatitis, which could lead to hospitalization or death.

Actemra Lawsuit

Many patients are at risk of fatal side effects from taking Actemra, despite marketing efforts by its manufacturer that claim otherwise.

Fournier’s Gangrene Lawsuit

The FDA identified that certain type-2 diabetes medications may trigger the onset of a flesh-eating infection known as Fournier’s gangrene.

Valsartan Cancer Lawsuit

Valsartan is a blood pressure medication that was recalled due to the presence of a carcinogenic ingredient patients were not aware of until this year.

Gilenya Lawsuit

A medication used to treat relapsing multiple sclerosis, Gilenya, poses a threat to patients as symptoms may worsen if they discontinue use.

Lemtrada & Campath Lawsuit

Lemtrada & Campath Lawsuit

Learn more about the recent FDA “Black Box Warning” on popular multiple sclerosis (MS) and B-cell chronic lymphocytic leukemia (B-CLL) drugs that have been linked to arterial dissection and strokes.

Montelukast Sodium Tablet Recall Lawsuit

Montelukast sodium tablets were voluntarily recalled because they were mixed up with another medication which could cause injury to an unsuspecting patient.